HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

France Moving Paracetamol and NSAIDs Behind Pharmacy Counter From January

Executive Summary

Fears over patient safety will see common OTC drugs including paracetamol moved behind the counter in France from January 2020.

You may also be interested in...



France Expanded Free Access Scheme In 2022 With OTC, Herbal And Homeopathic Additions

Record of OTC drugs, traditional herbal medicines and homeopathic medicines added to France's "free access" pharmacy self-selection scheme in 2022.

France Reverse-Switches Muscle Relaxant Methocarbamol

French regulator ANSM's response to reports of seizures triggered by muscle relaxant methocarbamol is to reverse-switch the drug from OTC-to-Rx status.

Researchers Urge Review Of Soluble Paracetamol Based On Increased Sodium-Related CVD Risk

High sodium content in effervescent paracetamol could increase risk of cardiovascular disease and mortality in people with and without hypertension, says a recently published study. The authors of the study recommend that the safety profile of such products be reviewed.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel